Search for: "Pharmaceutical Research and Manufacturers of America" Results 161 - 180 of 410
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2009, 8:12 pm
PhRMA Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement: "By   lowering the penalties for those found by a court to have infringed another’s patent, the bill would reduce the value of the patents that are the lifeblood of America's innovative business sectors, which depend on intellectual property protection. [read post]
15 Nov 2018, 9:30 pm by Simone Hussussian
As an alternative to the proposed HHS rule, the Pharmaceutical Research and Manufacturers of America (PhRMA) has published industry-defined guiding principles that recommend that drug manufacturers direct consumers to websites that contain more detailed information about the drug, including prices consumers may be expected to pay. [read post]
13 Jun 2012, 1:04 pm
  Obamacare provides "the necessary legal framework" for drug companies to slash brand-name drug prices by half for seniors and people with disabilities when they enter a coverage gap in their Medicare drug plans, said Matthew Bennett, a spokesman for the Pharmaceutical Research and Manufacturers of America. [read post]
23 Dec 2022, 7:25 am by Levin Papantonio
This research includes decades’ worth of medical studies, including a 1990 study published in The Lancet, studies published in The Journal of Pediatrics in 2000 and later in 2013, and a 2012 study published in Pediatric Research. [read post]
1 Feb 2012, 9:15 am by SteinMcewen, LLP
§ 273(a) allows the new defense when the infringing subject matter is “a process, or consisting of a machine, manufacture, or composition of matter used in a manufacturing or other commercial process” and where the defendant was “acting in good faith” and “commercially used” the subject matter in the United States. [read post]
20 Nov 2009, 10:47 am by randal shaheen
Speakers such as Eli Lilly, sanofi-aventis, and Pharmaceutical Research and Manufacturers of America (PhRMA) agreed that manufacturers should be accountable for online content they control, but noted that manufacturers should not have a broad obligation to police or remove all forms of third-party content about their products. [read post]
8 Dec 2010, 2:20 am by Marie Louise
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar (Temozolomide) – US:… [read post]
19 Jun 2012, 5:00 am by Ray Mullman
  Also Matt Bennett, senior vice president of Pharmaceutical Research and Manufacturers of America, voiced his concerns that the program will, “limit access to necessary pharmacological treatment. [read post]
30 Oct 2007, 10:07 am
  Update:  Also joining as amici are the Pharmaceutical Research and Manufacturers of America (PhRMA), and three "smaller, early-stage innovator companies," HEXAS, the Roskamp Institute, and Tikvah Therapeutics. [read post]
7 Aug 2010, 4:46 am by Dennis Crouch
Court Decisions: District Court Opinion Original Panel Decision En Banc Order Party Briefs: TheraSense (Abbott) Opening Brief: TheraSense.pdf (608 KB) Amicus Brief filed in Support of TheraSense Sanofi-Aventis and Microsoft: AventisMicrosoft.pdf (791 KB) Ole Nilssen: Nilssen.pdf (1608 KB) Amici Briefs filed in Support of Neither Party Apotex: Apotex.pdf (904 KB)  United States Patent & Trademark Office (USPTO): USPTO.pdf (770 KB) Intellectual Property Owners Association… [read post]
19 Jun 2012, 5:00 am by Ray Mullman
  Also Matt Bennett, senior vice president of Pharmaceutical Research and Manufacturers of America, voiced his concerns that the program will, “limit access to necessary pharmacological treatment. [read post]
10 Mar 2008, 12:30 pm
., of course, but it seems the U.S. has no complaint is in the works:The Office of the US Trade Representative (USTR) has moved to quell rumours that it was on the verge of filing a complaint with the World Trade Organisation about Thailand's compulsory licensing of pharmaceuticals under the Surayud Chulanont government. ''Speculation about a WTO case is frankly surprising,'' the USTR said in a statement. ''Any such consideration would only happen after… [read post]
8 Apr 2020, 9:05 pm by Sophia Gaulkin
The Pharmaceutical Research and Manufacturers of America submitted a comment to the public docket for the proposed rule, demanding that HHS withdraw its proposal. [read post]
4 May 2022, 8:14 am by Dan Bressler
” “‘The Center for Drugs currently does not have a contract with McKinsey and across FDA,’ said Patrizia Cavazzoni, director of the Center for Drug Evaluation and Research for the FDA. [read post]
” Pharma companies also oppose the deal, with Stephen Ubl, president of the Pharmaceutical Research and Manufacturers of America, saying, “Rather than focus on real issues affecting public health, like solving supply chain bottlenecks or reducing border tariffs on medicines, they approved an intellectual property waiver on COVID-19 vaccines that won’t help protect people against the virus. [read post]
11 Nov 2010, 6:00 am
Industry representatives from Pfizer, Biotechnology Industry Organization, Johnson & Johnson, and the Pharmaceutical Research and Manufacturers of America, suggested that the information sharing phase may not be needed for applications with few matters requiring further discussion, or those likely to receive a complete response from the agency. [read post]
10 Feb 2020, 9:05 pm by Marissa Fritz
FDA awarded the manufacturer of Ervebo a tropical disease priority review voucher, allowing the pharmaceutical company to accelerate approval for another drug that would not otherwise qualify for priority review. [read post]
7 Nov 2011, 1:07 pm by FDABlog HPM
”  Professor Grabowski’s research was supported in part by the Pharmaceutical Research and Manufacturers of America. [read post]
21 Oct 2011, 1:31 pm by SteinMcewen, LLP
  The result was a simplified Patent Reform Act in 2011, which issued as the America Invents Act signed by President Obama on September 16, 2011.[20]  Below is an overview of the more notable portions of the America Invents Act, along with a discussion on potential pitfalls of each section. [read post]
9 Apr 2009, 5:00 pm
Ltd. of China; Vivion, Inc. of San Carlos, CA;Zhongjin Pharmaceutical (Hong Kong) Co. [read post]